Jin-Jie Xu, Lu-Yu Ding, Cong-Cong Sun, Yu Qiao, Mei-Ti Wang, Jin-Xin Zheng, Gang Wang
{"title":"全球青少年精神障碍、物质使用障碍和自残负担:来自2021年全球疾病负担研究的结果","authors":"Jin-Jie Xu, Lu-Yu Ding, Cong-Cong Sun, Yu Qiao, Mei-Ti Wang, Jin-Xin Zheng, Gang Wang","doi":"10.1038/s41398-025-03533-x","DOIUrl":null,"url":null,"abstract":"<p><p>The period from childhood to early adulthood is critically susceptible to the onset of mental disorders (MDs), substance use disorders (SUDs), and self-harm, with significant implications for public health policy. Understanding these trends over time and across different regions is essential for effective intervention and resource allocation. This study utilizes data from GBD 2021, focusing on youths aged 10-24 years globally. Data span from 1990 to 2021, providing a longitudinal perspective on trends and are stratified by age groups, gender, geographic regions, and Socio-demographic Index (SDI). The results showed that in 2021, the global standardized prevalence of MDs among youths reached 14,778 per 100,000, marking a 6.8%(4.7-9.0) increase from 1990. Anxiety disorders and depressive disorders exhibited the highest prevalence. The prevalence of SUDs decreased by 20.3%(17.4-22.9) since 1990, while self-harm rates decreased by 35%(33.6-38.3). The highest burden was observed in the 20-24 age group, with notable gender disparities: females had higher rates of anxiety and depressive disorders, whereas males were more affected by SUDs and conduct disorders. Geographical and socio-economic variations were pronounced, with high SDI regions exhibiting the most significant prevalence of most MDs and SUDs. The study highlights a significant rise in the burden of MDs among global youth over three decades, exacerbated during the COVID-19 pandemic. It underscores the need for targeted mental health interventions and resource allocation to address the escalating mental health needs of young populations.</p>","PeriodicalId":23278,"journal":{"name":"Translational Psychiatry","volume":"15 1","pages":"346"},"PeriodicalIF":6.2000,"publicationDate":"2025-09-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479967/pdf/","citationCount":"0","resultStr":"{\"title\":\"The burden of mental disorders, substance use disorders, and self-harm among youths globally: findings from the 2021 Global Burden of Disease study.\",\"authors\":\"Jin-Jie Xu, Lu-Yu Ding, Cong-Cong Sun, Yu Qiao, Mei-Ti Wang, Jin-Xin Zheng, Gang Wang\",\"doi\":\"10.1038/s41398-025-03533-x\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>The period from childhood to early adulthood is critically susceptible to the onset of mental disorders (MDs), substance use disorders (SUDs), and self-harm, with significant implications for public health policy. Understanding these trends over time and across different regions is essential for effective intervention and resource allocation. This study utilizes data from GBD 2021, focusing on youths aged 10-24 years globally. Data span from 1990 to 2021, providing a longitudinal perspective on trends and are stratified by age groups, gender, geographic regions, and Socio-demographic Index (SDI). The results showed that in 2021, the global standardized prevalence of MDs among youths reached 14,778 per 100,000, marking a 6.8%(4.7-9.0) increase from 1990. Anxiety disorders and depressive disorders exhibited the highest prevalence. The prevalence of SUDs decreased by 20.3%(17.4-22.9) since 1990, while self-harm rates decreased by 35%(33.6-38.3). The highest burden was observed in the 20-24 age group, with notable gender disparities: females had higher rates of anxiety and depressive disorders, whereas males were more affected by SUDs and conduct disorders. Geographical and socio-economic variations were pronounced, with high SDI regions exhibiting the most significant prevalence of most MDs and SUDs. The study highlights a significant rise in the burden of MDs among global youth over three decades, exacerbated during the COVID-19 pandemic. It underscores the need for targeted mental health interventions and resource allocation to address the escalating mental health needs of young populations.</p>\",\"PeriodicalId\":23278,\"journal\":{\"name\":\"Translational Psychiatry\",\"volume\":\"15 1\",\"pages\":\"346\"},\"PeriodicalIF\":6.2000,\"publicationDate\":\"2025-09-29\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12479967/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Translational Psychiatry\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1038/s41398-025-03533-x\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"PSYCHIATRY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Translational Psychiatry","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1038/s41398-025-03533-x","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PSYCHIATRY","Score":null,"Total":0}
The burden of mental disorders, substance use disorders, and self-harm among youths globally: findings from the 2021 Global Burden of Disease study.
The period from childhood to early adulthood is critically susceptible to the onset of mental disorders (MDs), substance use disorders (SUDs), and self-harm, with significant implications for public health policy. Understanding these trends over time and across different regions is essential for effective intervention and resource allocation. This study utilizes data from GBD 2021, focusing on youths aged 10-24 years globally. Data span from 1990 to 2021, providing a longitudinal perspective on trends and are stratified by age groups, gender, geographic regions, and Socio-demographic Index (SDI). The results showed that in 2021, the global standardized prevalence of MDs among youths reached 14,778 per 100,000, marking a 6.8%(4.7-9.0) increase from 1990. Anxiety disorders and depressive disorders exhibited the highest prevalence. The prevalence of SUDs decreased by 20.3%(17.4-22.9) since 1990, while self-harm rates decreased by 35%(33.6-38.3). The highest burden was observed in the 20-24 age group, with notable gender disparities: females had higher rates of anxiety and depressive disorders, whereas males were more affected by SUDs and conduct disorders. Geographical and socio-economic variations were pronounced, with high SDI regions exhibiting the most significant prevalence of most MDs and SUDs. The study highlights a significant rise in the burden of MDs among global youth over three decades, exacerbated during the COVID-19 pandemic. It underscores the need for targeted mental health interventions and resource allocation to address the escalating mental health needs of young populations.
期刊介绍:
Psychiatry has suffered tremendously by the limited translational pipeline. Nobel laureate Julius Axelrod''s discovery in 1961 of monoamine reuptake by pre-synaptic neurons still forms the basis of contemporary antidepressant treatment. There is a grievous gap between the explosion of knowledge in neuroscience and conceptually novel treatments for our patients. Translational Psychiatry bridges this gap by fostering and highlighting the pathway from discovery to clinical applications, healthcare and global health. We view translation broadly as the full spectrum of work that marks the pathway from discovery to global health, inclusive. The steps of translation that are within the scope of Translational Psychiatry include (i) fundamental discovery, (ii) bench to bedside, (iii) bedside to clinical applications (clinical trials), (iv) translation to policy and health care guidelines, (v) assessment of health policy and usage, and (vi) global health. All areas of medical research, including — but not restricted to — molecular biology, genetics, pharmacology, imaging and epidemiology are welcome as they contribute to enhance the field of translational psychiatry.